A Team Effort in Biotechnology

To outsiders, the world of biotechnology can seem mysterious and intimidating. In just one generation the field of biotechnology has come to be seen as the source of seemingly miraculous breakthroughs and cures that affect all of us. Now, with 2013 soon upon us, we all wait to see what news will be appearing in biotechnology articles about even further breakthroughs.

There is another aspect to the biotechnology field of which most outsiders are unaware. That reality is the need for and existence of extensive cooperation and collaboration in the process of bringing new and proven products to the marketplace. There is a long and expensive road that must be diligently and patiently traveled in bringing new therapies and products to the marketplace. This process includes identifying new potential products and needs, developing those potential products through a number of stages, and dealing with the cumbersome process of obtaining regulatory approval. Only then can the challenges of manufacturing and marketing be dealt with.

With the successes in the field of biotechnology, the process has to a degree matured and substantial amounts of capital have been committed to venture firms. Additionally, the large pharmaceutical companies have refocused their attention on the potentials to be found in some of the more creative start-ups. A certain market division and sophistication has developed within the market as companies specialize in disease treatment, drug and medicine delivery and even in simply serving as technology platforms for the industry.

Any quick search of biotechnology articles will show that the dollars involved are quite substantial. It is a living example of the old adage of risk and return - the higher the risk, the greater the potential return. And here the risks and returns can easily be in the billions of dollars. This brings even more importance to the process of collaboration.. Certainly small start-ups, even with the most promising of prospects, can hardly afford the risks in time and dollars. Moreover, the expertise of taking a prospective therapy from concept to marketed product requires an expertise and network that can only be found in the large and successful pharmaceutical companies.

Biotechnology will continue to become an even more important and significant industry in meeting the health and medical challenges of the coming years. In light of this, we can expect to see even more start-ups and their continued and increasing reliance on collaboration with the large firms in 2013.

Be sure to visit this website to learn whether a conference is the right choice for you or not.

Article Source: http://EzineArticles.com/?expert=Jeremy_B_Thompson
http://EzineArticles.com/?A-Team-Effort-in-Biotechnology&id=7480642